Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evogene (EVGN) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Evogene (EVGN) over the last 14 years, with Q2 2025 value amounting to $5.3 million.

  • Evogene's Non-Current Assets fell 6524.29% to $5.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $5.3 million, marking a year-over-year decrease of 6524.29%. This contributed to the annual value of $18.3 million for FY2024, which is 987.85% up from last year.
  • According to the latest figures from Q2 2025, Evogene's Non-Current Assets is $5.3 million, which was down 6524.29% from $18.3 million recorded in Q4 2024.
  • Over the past 5 years, Evogene's Non-Current Assets peaked at $19.7 million during Q2 2021, and registered a low of $5.3 million during Q2 2025.
  • In the last 5 years, Evogene's Non-Current Assets had a median value of $18.3 million in 2024 and averaged $16.6 million.
  • In the last 5 years, Evogene's Non-Current Assets skyrocketed by 987.85% in 2024 and then tumbled by 6524.29% in 2025.
  • Over the past 5 years, Evogene's Non-Current Assets (Quarter) stood at $19.4 million in 2021, then fell by 5.35% to $18.4 million in 2022, then dropped by 9.49% to $16.6 million in 2023, then rose by 9.88% to $18.3 million in 2024, then plummeted by 71.1% to $5.3 million in 2025.
  • Its Non-Current Assets was $5.3 million in Q2 2025, compared to $18.3 million in Q4 2024 and $15.2 million in Q2 2024.